Brian S. KimSol and Clara Kest Professor of Dermatology and Co-Founder at Icahn School of Medicine at Mount Sinai and Alys PharmaceuticalsSpeaker
Profile
Dr. Kim is the Sol and Clara Kest Professor of Dermatology, Vice Chair of Research, Director of the Mark Lebwohl Center for Neuroinflammation, and Lead of the Allen Discovery Center for Neuroimmune Interactions at the Marc and Jennifer Lipschultz Precision Immunology Institute and Friedman Brain Institute at Icahn School of Medicine at Mount Sinai. He has >180 peer-reviewed publications, multiple NIH grants, designed pivotal clinical trials that led to novel FDA-approved treatments, and is an inventor of itch-centered technologies. He has been awarded the Stephen I Katz, MD, PhD International Lectureship Award from the Society for Investigative Dermatology, Donald Y. M. Leung, MD, PhD-JACI Editors Lectureship and Faculty Development Award from the American Academy of Asthma, Allergy & Immunology, and Marion B. Sulzberger, MD Research Award and Lectureship from the American Academy of Dermatology. He is co-founder of Alys Pharmaceuticals, an immuno-dermatology biotech company and Neurommune Therapeutics, a neuroinflammation-focused biotech company. Most recently, Dr. Kim was awarded the role as the Lead of the Allen Discovery Center for Neuroimmune Interactions which is a $10 million multi-institutional center funded by the Paul G. Allen Frontiers Group and the Paul G. Allen Family Foundation.
Agenda Sessions
Deconstructing breakthroughs: Unpacking lessons from Alys Pharmaceuticals on advancing Immuno-Dermatology
, 14:00View Session